Tekhnoscan

Technoscan SAS was a prominent French pharmaceutical company specializing in the development and manufacture of radiopharmaceutical kits, primarily for use with Technetium-99m (Tc-99m) in diagnostic imaging. The company was a significant player in the European nuclear medicine market, offering a wide range of "Technescan" branded products for various clinical applications, including bone, kidney, and heart scans. In 2011, Technoscan was acquired by Mallinckrodt, and its portfolio later became part of Curium following the divestiture of Mallinckrodt's nuclear imaging business. Today, its legacy products continue to be essential tools in nuclear medicine departments worldwide for non-invasive diagnostic procedures.